Is Boron Bone Mineral Density Randomized Trial safe?

Updated June 2026

Quick Answer

Boron Bone Mineral Density Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: 1 2 1 2 Osteoporosis, the primary risk factor for fragility fractures, is highly prevalent and projected to increase as populations age globally [,].

Key Takeaways

  • 011 2 1 2 Osteoporosis, the primary risk factor for fragility fractures, is highly prevalent and projected to increase as populations age globally [,]. [Treister-Goltzman Yulia (2026)]
  • 02Fragility fractures, particularly of the hip, spine, and wrist, are associated with substantial morbidity, loss of independence, increased mortality, and considerable healthcare costs, making osteoporosis a significant public health concern [,]. [Treister-Goltzman Yulia (2026)]
  • 03Evidence from multiple in vitro biochemical and cell culture studies [,,], as well as preclinical investigations using ovariectomized and estrogen-deficient rodent models [,,,,,], consistently supports a favorable effect of prunes or prune-derived components on bone metabolism. [Treister-Goltzman Yulia (2026)]
The current Migaku evidence database contains 1 reusable source document for Boron Bone Mineral Density Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - 1 2 1 2 Osteoporosis, the primary risk factor for fragility fractures, is highly prevalent and projected to increase as populations age globally [,]. [Treister-Goltzman Yulia (2026); evidence level 1] - Fragility fractures, particularly of the hip, spine, and wrist, are associated with substantial morbidity, loss of independence, increased mortality, and considerable healthcare costs, making osteoporosis a significant public health concern [,]. [Treister-Goltzman Yulia (2026); evidence level 1] - Evidence from multiple in vitro biochemical and cell culture studies [,,], as well as preclinical investigations using ovariectomized and estrogen-deficient rodent models [,,,,,], consistently supports a favorable effect of prunes or prune-derived components on bone metabolism. [Treister-Goltzman Yulia (2026); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Effects of Prunes on Bone Density in Humans: A Systematic Review and Meta-Analysis of Randomized Controlled Trials